To access this element change to forms mode OFF
Grant Award View - GA268495
Intranasal TLR2/6 activation to prevent COVID infection in the elderly
GA ID:
GA268495
Agency:
Department of Health and Aged Care
Approval Date:
19-Jun-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
19-Jun-2022 to 31-May-2025
Value (AUD):
$3,883,462.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
Intranasal TLR2/6 activation to prevent COVID infection in the elderly
Purpose:
Elderly Australians in aged care are highly vulnerable to COVID-19. Vaccines are essential but their protection fades with age and new vaccines can take over a year to make. We will test a new medicine called INNA-051 that strengthens natural defences against COVID-19 in the nose where infection starts. INNA-051 is highly effective in preventing respiratory viruses, is safe in the elderly and works on top of vaccines. It provides protection within a day that lasts about a week after each spray.
GO ID:
GO Title:
MRFF – CRR – 2021 COVID-19 Treatment Access and Public Health Activities Grant Opportunity
Internal Reference ID:
2022/MRF2017588
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA